Skip to main content
. 2020 May 30;20:489. doi: 10.1186/s12885-020-06976-1

Fig. 2.

Fig. 2

New-onset dyslipidemia, diabetes mellitus and hypertension in the multiple myeloma and in the smoldering multiple myeloma patient groups compared to the control group. HR hazard ratio adjusted for age, sex, follow-up duration, and the presence of dyslipidemia, diabetes, and hypertension at study entry, MM multiple myeloma, SMM smoldering multiple myeloma